High blood pressure, smoking and cardiovascular risk

Journal of Hypertension

Volumn 23, Issue 1, 2005, Pages 219-221

  Pardell, Helios ^a   Rodicio, José L ^b  

^a Red Cross Hospita   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CADMIUM; CARBON MONOXIDE; CLONIDINE; NICOTINE; OXIDIZING AGENT; TOBACCO SMOKE;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; EUROPE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MEDICAL LITERATURE; MEDICAL SOCIETY; MORTALITY; NICOTINE REPLACEMENT THERAPY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK FACTOR; SMOKING CESSATION;

EID: 12344314110     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200501000-00037     Document Type: Review

References (20)

1. World Health Organization. The World Health Report 2002. Reducing risks, promoting healthy life. Geneva: WHO; 2002.
2. Mackay J, Eriksen J. The tobacco atlas. Geneva: World Health Organization: 2002.
3. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancer 2003; 361:1629-1641.
4. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Zampi I, Battistelli M, et al. Cigarette smoking, ambulatory blood pressure and cardiac hypertophy in essential hypertension. J Hypertens 1995; 13:1209-1215.
5. Kannel WB. Clinical misconceptions dispelled by epidemiological research. Circulation 1995; 92:3350-3360,
6. Black HR. Smoking and cardiovascular disease. In: Laragh JH, Brenner BM (editors): Hypertension, Pathophysiology, diagnosis and management, 2nd edn. New York, NY: Raven Press; 1995, pp. 2621-2647.
7. Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Prev Med 1997; 26:412-417.
8. Pardell H, Roure E, Drygas W, Morava E, Nussel E, Puska P, et al. East-west differences in reported preventive practices. A comparative study of six European areas of WHO-CINDI programme. Eur J Pub Health 2001; 11:393-396.
9. Kastarinen MJ, Puska PM, Korhonen MH, Mustonen JN, Salomaa VV, Sundvall JE, et al. Non-pharmacological treatment of hypertension in primary health care: a 2-year open randomised controlled trial of lifestyle intervention against hypertension in eastern Finland. J Hypertens 2002; 20:2505-2512.
10. Pardell H, Salto E, Salleras L. How to improve the physician's involvement in antismoking activities. Int J Smoking Cessation 1995; 4:6-9.
11. Rigotti NA. Treatment of tobacco use and dependence. N Engl J Med 2002; 346:506-512.
12. Karnath B. Smoking cessation. Am J Med 2002; 112:399-405.
13. Fiore MC, Hatsukami DK, Baker TB. Effective tobacco dependence treatment. JAMA 2002; 288:1768-1771.
14. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Goldstein MG, Gritz ER, et al. Treating tobacco use and dependence. Clinical Practice Guideline. Rockville, MD: US DHHS Public Health Service; 2000.
15. Benowitz NL. Safety of nicotine in smokers with hypertension. Am J Hypertens 2001; 14:731-732.
16. Balfour D, Benowitz NL, Fagerström K, Kunze M, Keil U. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. Eur Heart J 2000; 21:435-445.
17. McRobbie H, Hajek P. Nicotine replacement therapy in patients with cardiovascular disease: guidelines for health professionals. Addiction 2001; 96:1547-1551.
18. Tonstad S, Farsang C, Klaene G, Lewis K, Manolis A, Perruchoud AP, et al. Bupropion SR for smoking cessation in smokers with cardiovascular disease: a multicentre, randomised study. Eur Heart J 2003; 24: 946-955.
19. Pardell H, Tresserras R, Salto E, Armario P, Hernández del Rey R. Management of hypertensive patient who smokes. Drugs 1998; 56: 177-187.
20. Stratton K, Shetty P, Wallace R, Bondurant S, (editors). Clearing the smoke. Assessing the science base for tobacco harm reduction. Washington, DC: Institute of Medicine/National Academy Press; 2001.